Korean J Med > Volume 86(6); 2014 > Article
The Korean Journal of Medicine 2014;86(6):655-663.
Published online June 1, 2014.
DOI: https://doi.org/10.3904/kjm.2014.86.6.655   
Helicobacter pylori-related Peptic Ulcer Disease
Seung In Seo, Hak Yang Kim
Division of Gastroenterology, Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
Helicobacter pylori 연관 소화성궤양
서승인, 김학양
한림대학교 의과대학 강동성심병원 소화기내과
Correspondence: 
Hak Yang Kim, Tel: +82-2-2224-2113, Fax: +82-2-2224-2647, Email: bacter@hallym.or.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Although the worldwide prevalence of Helicobacter pylori (H. pylori) infection has decreased, peptic ulcer disease (PUD) remains prevalent due to increased usage of non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin. In recent years, the prevalence of H. pylori infection in PUD cases and the distribution of PUD have changed in Korea. The incidence of idiopathic H. pylori-negative ulcers has increased, and research is needed to determine the cause of these idiopathic ulcers. The eradication of H. pylori infection decreases PUD recurrence, and plays a crucial role in the treatment of PUD. The H. pylori test-and-treat strategy is beneficial for patients starting NSAIDs and long-term aspirin users with a history of bleeding ulcers. Although the H. pylori eradication rate is declining steadily due to antibiotic resistance, especially to clarithromycin, current guidelines still recommend standard triple therapy, including a proton pump inhibitor, amoxicillin, and clarithromycin, as a first-line therapy. Recently, various treatment regimens, including sequential or concomitant therapies, have been developed in an attempt to overcome the low eradication rate observed with standard triple therapy. The aim of this article is to review recent trends in H. pylori-related PUD, focusing on epidemiology and treatment strategies. (Korean J Med 2014;86:655-663)
Key Words: Helicobacter pylori peptic ulcer; Epidemiology; Treatment
주제어: 헬리코박터 파일로리; 소화성궤양; 역학; 치료


TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 3,742 View
  • 75 Download

Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2024 by The Korean Association of Internal Medicine.

Developed in M2PI

Close layer
prev next